Proteins often function in pairs or groups, concealing their internal connection points and making it difficult for scientists to study their individual units without altering their natural structure. Researchers successfully isolated single units of the protein SOD1, which is linked to Amyotrophic Lateral Sclerosis (ALS), by chemically tagging the protein and encapsulating it within tiny, self-assembled artificial cages. This technique exposed the normally hidden interface of the protein, allowing the team to identify specific compounds like quercetin that bind to these regions, offering a promising new strategy for finding drugs that inhibit disease-causing protein aggregation.
Homo-oligomeric proteins, which are formed by the assembly of identical protein subunits, constitute approximately 20 to 45 percent of all proteins in an organism. Understanding how a single subunit, or monomer, functions independently is crucial for drug discovery, but isolating them is challenging because they naturally stick together to form stable structures. Conventionally, scientists use genetic mutations to keep these proteins apart, but this often disrupts the protein's original structure and stability, making it difficult to study their true properties. This is particularly relevant for Superoxide Dismutase 1 (SOD1), a protein that forms a extremely stable pair (dimer) and is associated with ALS when it aggregates abnormally.
To isolate the monomer without using structure-altering mutations, the research team developed a method using spherical coordination cages that self-assemble from palladium ions and organic ligands. The researchers first chemically attached a specific pyridine-based tag to the N-terminus of the SOD1 protein to anchor it during the process. They then induced the self-assembly of the cages in a "one-pot" complexation, where the cage structure formed around the tagged protein. Because the cage's internal cavity (about 5 to 6 nanometers) is too small to fit the full SOD1 dimer (6.7 nanometers), the system selectively captured the smaller, transiently dissociated monomers (3.9 nanometers) from the solution equilibrium, effectively isolating them from their paired counterparts.
The study demonstrated that this encapsulation strategy successfully isolated native SOD1 monomers that retained the same structure as they do in their natural paired form, avoiding the distortions typical of mutation-based methods. Crucially, isolating the monomer exposed the dimer interface--the hydrophobic surface where two protein units normally connect--which is usually buried and inaccessible. Using Saturation Transfer Difference (STD) NMR spectroscopy, the researchers discovered that flavonoid compounds, such as quercetin, bound specifically to this exposed interface on the monomer but did not interact with the full dimer. This confirms that the cage method allows for the identification of ligands that target the specific regions driving protein aggregation.
This research establishes monomer isolation within coordination cages as a versatile platform for studying the intrinsic properties of proteins that usually exist in groups. By capturing native monomers, scientists can now access and target the molecular interfaces that were previously hidden, providing a new avenue for drug discovery. These exposed interfaces are promising targets for therapeutic compounds not only for neurodegenerative diseases like ALS but also for other conditions involving protein assembly, such as HIV and hepatitis B.
Journal of the American Chemical Society
Experimental study
Not applicable
Monomer Isolation from Oligomeric Proteins within Coordination Cages to Study Interface Ligand Binding
29-Dec-2025